- Home
- VIRC vs KYTX Comparison
VIRC vs KYTX Comparison
Compare VIRC & KYTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIRC
- KYTX
- Stock Information
- Founded
- VIRC 1950
- KYTX 2018
- Country
- VIRC United States
- KYTX United States
- Employees
- VIRC N/A
- KYTX N/A
- Industry
- VIRC Industrial Specialties
- KYTX
- Sector
- VIRC Consumer Discretionary
- KYTX
- Exchange
- VIRC Nasdaq
- KYTX NYSE
- Market Cap
- VIRC 244.7M
- KYTX 242.1M
- IPO Year
- VIRC N/A
- KYTX 2024
- Fundamental
- Price
- VIRC $14.82
- KYTX $4.35
- Analyst Decision
- VIRC Buy
- KYTX Buy
- Analyst Count
- VIRC 1
- KYTX 5
- Target Price
- VIRC $19.00
- KYTX $23.40
- AVG Volume (30 Days)
- VIRC 122.7K
- KYTX 237.0K
- Earning Date
- VIRC 12-06-2024
- KYTX 11-13-2024
- Dividend Yield
- VIRC 0.67%
- KYTX N/A
- EPS Growth
- VIRC 2.02
- KYTX N/A
- EPS
- VIRC 1.63
- KYTX N/A
- Revenue
- VIRC $282,007,000.00
- KYTX N/A
- Revenue This Year
- VIRC $12.97
- KYTX N/A
- Revenue Next Year
- VIRC $5.09
- KYTX N/A
- P/E Ratio
- VIRC $9.10
- KYTX N/A
- Revenue Growth
- VIRC 9.12
- KYTX N/A
- 52 Week Low
- VIRC $6.20
- KYTX $4.32
- 52 Week High
- VIRC $18.50
- KYTX $30.60
- Technical
- Relative Strength Index (RSI)
- VIRC 49.77
- KYTX 33.83
- Support Level
- VIRC $15.38
- KYTX $5.01
- Resistance Level
- VIRC $16.49
- KYTX $5.62
- Average True Range (ATR)
- VIRC 0.63
- KYTX 0.39
- MACD
- VIRC 0.04
- KYTX -0.03
- Stochastic Oscillator
- VIRC 38.54
- KYTX 2.19
About VIRC Virco Manufacturing Corporation
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, and activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.
About KYTX KYVERNA THERAPEUTICS INC
Kyverna Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on developing cell therapies for patients suffering from autoimmune diseases. Its product KYV-101, is an autologous CD19 CAR T-cell product candidate made from an underlying chimeric antigen receptor, or CAR. It is also developing KYV-201, an allogeneic therapy containing the same CAR as KYV-101, to develop it in multiple autoimmune diseases.